A ccording to preliminary estimates, Light Vehicle (LV) sales grew by 2.4% year-on-year (YoY) in December, to 1.51 million ...

Analysis by GlobalData has identified that innovative cardiovascular devices are driving diversification in the growing ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

It’s become evident that a cloud-based IT portfolio brings organisations the greatest promise for providing the type of ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...

The transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

The heart failure market is expected to grow at a 9.6% CAGR from $13.5bn in 2022 to $33.7bn in 2032 in the 7MM.

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

Overall EV sales gained 12%, pushing the full-year total to a record 1.3 million, according to forecasts from researcher Cox ...